A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen

Limited predictable long noncoding RNA (lncRNA) signature was reported in tamoxifen resistance among estrogen receptor (ER)-positive breast cancer (BC) patients. The aim of this study was to identify and assess prognostic lncRNA signature to predict recurrence among ER-positive BC patients treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kang, Li, Jie, Xiong, Yong-Fu, Zeng, Zhen, Zhang, Xiang, Li, Hong-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816619/
https://www.ncbi.nlm.nih.gov/pubmed/29453409
http://dx.doi.org/10.1038/s41598-018-21581-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816619/
https://www.ncbi.nlm.nih.gov/pubmed/29453409
http://dx.doi.org/10.1038/s41598-018-21581-w

Ejemplares similares